amonafide has been researched along with chlorambucil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flanagan, JU; Kemp, CA; Maréchal, JD; Paine, MJ; Roberts, GC; Sutcliffe, MJ; van Eldik, AJ; Wolf, CR | 1 |
| Ben-David, G; Firer, MA; Gancz, A; Gellerman, G; Gilad, Y; Luboshits, G; Minnes, R; Senderowitz, H; Tuchinsky, H | 1 |
| Bazylevich, A; Gellerman, G; Hershkovitz-Rokah, O; Patsenker, L; Shpilberg, O; Tuchinsky, H; Weissman, R; Zigman-Hoffman, E | 1 |
3 other study(ies) available for amonafide and chlorambucil
| Article | Year |
|---|---|
Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
Topics: Binding Sites; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2004 |
Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 3-Ring; Humans; Melanoma; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Pyrimidinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2017 |
Synthesis and Biological Studies of New Multifunctional Curcumin Platforms for Anticancer Drug Delivery.
Topics: Adenine; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chlorambucil; Curcumin; Drug Carriers; Drug Liberation; Humans; Naphthalimides; Organophosphonates; Phosphorylation; Prodrugs; Transcription Factor RelA | 2019 |